We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Longboard Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. Its pipeline includes LP352, LP143, and LP659. Longboard Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. Its pipeline includes LP352, LP143, and LP659.
PACIFIC Study Phase 1b/2a clinical data to be featured in a podium presentation at an Emerging Science Session at the AAN Annual Meeting Data will be featured in an encore presentation at the...
Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the...
Bexicaserin (LP352) Phase 1b/2a PACIFIC Study positive topline data in participants with Developmental and Epileptic Encephalopathies (DEEs) was reported in January Announcing an update to the...
Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the...
Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the...
Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that...
Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 2.16 | 12.2102882985 | 17.69 | 20.72 | 17.31 | 417666 | 18.98345211 | CS |
4 | -2.05 | -9.36073059361 | 21.9 | 21.9 | 16.55 | 391131 | 18.75759926 | CS |
12 | -0.82 | -3.96710208031 | 20.67 | 24.5 | 16.55 | 543237 | 20.10307481 | CS |
26 | 14.43 | 266.236162362 | 5.42 | 28.15 | 3.6 | 847697 | 22.47590504 | CS |
52 | 12.58 | 173.039889959 | 7.27 | 28.15 | 3.6 | 466879 | 20.99094694 | CS |
156 | 9.75 | 96.5346534653 | 10.1 | 28.15 | 2.7 | 175974 | 19.28047548 | CS |
260 | 3.85 | 24.0625 | 16 | 28.15 | 2.7 | 173694 | 19.20158602 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions